REFERENCES
1. Tweedy, S. M.; Beckman, E. M.; Geraghty, T. J.; et al. Exercise and sports science Australia (ESSA) position statement on exercise and spinal cord injury. J. Sci. Med. Sport. 2017, 20, 108-15.
2. Alizadeh, A.; Dyck, S. M.; Karimi-Abdolrezaee, S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front. Neurol. 2019, 10, 282.
3. Kjell, J.; Olson, L. Rat models of spinal cord injury: from pathology to potential therapies. Dis. Model. Mech. 2016, 9, 1125-37.
4. Quadri, S. A.; Farooqui, M.; Ikram, A.; et al. Recent update on basic mechanisms of spinal cord injury. Neurosurg. Rev. 2020, 43, 425-41.
5. Katoh, H.; Yokota, K.; Fehlings, M. G. Regeneration of spinal cord connectivity through stem cell transplantation and biomaterial scaffolds. Front. Cell. Neurosci. 2019, 13, 248.
6. Khorasanizadeh, M.; Yousefifard, M.; Eskian, M.; et al. Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis. J. Neurosurg. Spine. 2019, 30, 683-99.
7. Anjum, A.; Yazid, M. D.; Fauzi, Daud. M.; et al. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int. J. Mol. Sci. 2020, 21, 7533.
8. Hall, E. D. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 2011, 8, 152-67.
9. Lin, J.; Xiong, Z.; Gu, J.; et al. Sirtuins: potential therapeutic targets for defense against oxidative stress in spinal cord injury. Oxid. Med. Cell. Longev. 2021, 2021, 7207692.
10. Hall, E. D.; Wang, J. A.; Bosken, J. M.; Singh, I. N. Lipid peroxidation in brain or spinal cord mitochondria after injury. J. Bioenerg. Biomembr. 2016, 48, 169-74.
11. Li, Q. S.; Jia, Y. J. Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury. Neural. Regen. Res. 2023, 18, 506-12.
12. Yao, S.; Pang, M.; Wang, Y.; et al. Mesenchymal stem cell attenuates spinal cord injury by inhibiting mitochondrial quality control-associated neuronal ferroptosis. Redox. Biol. 2023, 67, 102871.
13. Ge, H.; Xue, X.; Xian, J.; et al. Ferrostatin-1 alleviates white matter injury via decreasing ferroptosis following spinal cord injury. Mol. Neurobiol. 2022, 59, 161-76.
14. Li, F.; Wang, H.; Chen, H.; et al. Mechanism of ferroptosis and its role in spinal cord injury. Front. Neurol. 2022, 13, 926780.
15. Di, Marco. G.; Vallese, F.; Jourde, B.; et al. A high-throughput screening identifies MICU1 targeting compounds. Cell. Rep. 2020, 30, 2321-2331.e6.
16. Schmidt, J.; Quintá, H. R. Mitochondrial dysfunction as a target in spinal cord injury: intimate correlation between pathological processes and therapeutic approaches. Neural. Regen. Res. 2023, 18, 2161-6.
17. Bustamante-Barrientos, F. A.; Luque-Campos, N.; Araya, M. J.; et al. Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells. J. Transl. Med. 2023, 21, 613.
18. Golpich, M.; Amini, E.; Mohamed, Z.; Azman, Ali. R.; Mohamed, Ibrahim. N.; Ahmadiani, A. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS. Neurosci. Ther. 2017, 23, 5-22.
19. O'Shea, T. M.; Burda, J. E.; Sofroniew, M. V. Cell biology of spinal cord injury and repair. J. Clin. Invest. 2017, 127, 3259-70.
20. Cao, Y.; Lv, G.; Wang, Y. S.; et al. Mitochondrial fusion and fission after spinal sacord injury in rats. Brain. Res. 2013, 1522, 59-66.
21. Tran, A. P.; Warren, P. M.; Silver, J. The biology of regeneration failure and success after spinal cord injury. Physiol. Rev. 2018, 98, 881-917.
22. Stenudd, M.; Sabelström, H.; Frisén, J. Role of endogenous neural stem cells in spinal cord injury and repair. JAMA. Neurol. 2015, 72, 235-7.
23. Shu, J.; Cheng, F.; Gong, Z.; et al. Transplantation strategies for spinal cord injury based on microenvironment modulation. Curr. Stem. Cell. Res. Ther. 2020, 15, 522-30.
24. Liu, D.; Chen, J.; Jiang, T.; et al. Biodegradable spheres protect traumatically injured spinal cord by alleviating the glutamate-induced excitotoxicity. Adv. Mater. 2018, 30, e1706032.
25. Liu, D.; Lu, G.; Shi, B.; et al. ROS-scavenging hydrogels synergize with neural stem cells to enhance spinal cord injury repair via regulating microenvironment and facilitating nerve regeneration. Adv. Healthc. Mater. 2023, 12, e2300123.
26. Han, Q.; Xie, Y.; Ordaz, J. D.; et al. Restoring cellular energetics promotes axonal regeneration and functional recovery after spinal cord injury. Cell. Metab. 2020, 31, 623-641.e8.
27. Peng, C.; Luo, J.; Wang, K.; et al. Iridium metal complex targeting oxidation resistance 1 protein attenuates spinal cord injury by inhibiting oxidative stress-associated reactive oxygen species. Redox. Biol. 2023, 67, 102913.
28. Liu, C.; Hu, F.; Jiao, G.; et al. Dental pulp stem cell-derived exosomes suppress M1 macrophage polarization through the ROS-MAPK-NFκB P65 signaling pathway after spinal cord injury. J. Nanobiotechnol. 2022, 20, 65.
29. Zhao, Q.; Liu, F.; Zhou, B.; Liu, H.; Wang, X.; Li, S. Ferroptosis: a novel therapeutic direction of spinal cord injury. Comput. Math. Methods. Med. 2022, 2022, 7906218.
30. Gong, L.; Gu, Y.; Han, X.; et al. Spatiotemporal dynamics of the molecular expression pattern and intercellular interactions in the glial scar response to spinal cord injury. Neurosci. Bull. 2023, 39, 213-44.
31. Bai, X. Y.; Liu, X. L.; Deng, Z. Z.; et al. Ferroptosis is a new therapeutic target for spinal cord injury. Front. Neurosci. 2023, 17, 1136143.
32. Li, W.; Zhao, X.; Zhang, R.; et al. Ferroptosis inhibition protects vascular endothelial cells and maintains integrity of the blood-spinal cord barrier after spinal cord injury. Neural. Regen. Res. 2023, 18, 2474-81.
33. Wang, H.; Liu, C.; Zhao, Y.; Gao, G. Mitochondria regulation in ferroptosis. Eur. J. Cell. Biol. 2020, 99, 151058.
34. Slater, P. G.; Domínguez-Romero, M. E.; Villarreal, M.; Eisner, V.; Larraín, J. Mitochondrial function in spinal cord injury and regeneration. Cell. Mol. Life. Sci. 2022, 79, 239.
35. Rabchevsky, A. G.; Michael, F. M.; Patel, S. P. Mitochondria focused neurotherapeutics for spinal cord injury. Exp. Neurol. 2020, 330, 113332.
36. Cheng, L.; Cai, B.; Lu, D.; Zeng, H. The role of mitochondrial energy metabolism in neuroprotection and axonal regeneration after spinal cord injury. Mitochondrion 2023, 69, 57-63.
37. Li, C.; Wu, Y.; Chen, Q.; et al. Pleiotropic microenvironment remodeling micelles for cerebral ischemia-reperfusion injury therapy by inhibiting neuronal ferroptosis and glial overactivation. ACS. Nano. 2023, 17, 18164-77.
38. Lauro, F.; Ilari, S.; Giancotti, L. A.; et al. Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain. Pharmacol. Res. 2016, 111, 767-73.
39. Yan, J.; Sun, W.; Shen, M.; et al. Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice. Cell. Death. Discov. 2022, 8, 28.
40. Gueven, N.; Ravishankar, P.; Eri, R.; Rybalka, E. Idebenone: when an antioxidant is not an antioxidant. Redox. Biol. 2021, 38, 101812.
41. Montenegro, L.; Turnaturi, R.; Parenti, C.; Pasquinucci, L. Idebenone: novel strategies to improve its systemic and local efficacy. Nanomaterials. (Basel). 2018, 8, 87.
42. Jaber, S.; Polster, B. M. Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? J. Bioenerg. Biomembr. 2015, 47, 111-8.
43. Xu, H.; Guo, Y.; Liu, X. J.; et al. Idebenone antagonizes P53-mediated neuronal oxidative stress injury by regulating CD38-SIRT3 protein level. Neurochem. Res. 2024, 49, 2491-504.
44. Suno, M.; Nagaoka, A. Inhibition of brain mitochondrial swelling by idebenone. Arch. Gerontol. Geriatr. 1989, 8, 299-305.
45. Song, Y. H.; Agrawal, N. K.; Griffin, J. M.; Schmidt, C. E. Recent advances in nanotherapeutic strategies for spinal cord injury repair. Adv. Drug. Deliv. Rev. 2019, 148, 38-59.
46. Xu, Z.; Liu, X.; Pang, Y.; et al. Long-acting heterodimeric paclitaxel-idebenone prodrug-based nanomedicine promotes functional recovery after spinal cord injury. Nano. Lett. 2024, 24, 3548-56.
47. Gaojian, T.; Dingfei, Q.; Linwei, L.; et al. Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway. Cell. Death. Discov. 2020, 6, 97.
48. Liu, X.; Tao, H.; Yang, K.; Zhang, S.; Lee, S. T.; Liu, Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011, 32, 144-51.
49. Ji, Y.; Yang, X.; Ji, Z.; et al. DFT-calculated IR spectrum amide I, II, and III Band contributions of n-methylacetamide fine components. ACS. Omega. 2020, 5, 8572-8.
50. Ye, S.; Li, H.; Yang, W.; Luo, Y. Accurate determination of interfacial protein secondary structure by combining interfacial-sensitive amide I and amide III spectral signals. J. Am. Chem. Soc. 2014, 136, 1206-9.
51. Guo, J.; Zhou, Y.; Liu, D.; et al. Mitochondria as multifaceted regulators of ferroptosis. Life. Metab. 2022, 1, 134-48.
52. Basso, D. M.; Fisher, L. C.; Anderson, A. J.; Jakeman, L. B.; McTigue, D. M.; Popovich, P. G. Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma. 2006, 23, 635-59.
